These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy. Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118 [TBL] [Abstract][Full Text] [Related]
4. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy. Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174 [TBL] [Abstract][Full Text] [Related]
5. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release. Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095 [TBL] [Abstract][Full Text] [Related]
6. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property. Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging. Zhao Q; Wang S; Yang Y; Li X; Di D; Zhang C; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():475-484. PubMed ID: 28576012 [TBL] [Abstract][Full Text] [Related]
8. Albumin-MnO Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612 [TBL] [Abstract][Full Text] [Related]
9. pH/H Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104 [TBL] [Abstract][Full Text] [Related]
10. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy. Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009 [TBL] [Abstract][Full Text] [Related]
11. Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery. Llinàs MC; Martínez-Edo G; Cascante A; Porcar I; Borrós S; Sánchez-García D Drug Deliv; 2018 Nov; 25(1):1137-1146. PubMed ID: 29779394 [TBL] [Abstract][Full Text] [Related]
12. Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery. Hadipour Moghaddam SP; Yazdimamaghani M; Ghandehari H J Control Release; 2018 Jul; 282():62-75. PubMed ID: 29679666 [TBL] [Abstract][Full Text] [Related]
13. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy. Chen H; Chen Z; Kuang Y; Li S; Zhang M; Liu J; Sun Z; Jiang B; Chen X; Li C Colloids Surf B Biointerfaces; 2018 Jul; 167():407-414. PubMed ID: 29704741 [TBL] [Abstract][Full Text] [Related]
15. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
16. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System. Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120 [TBL] [Abstract][Full Text] [Related]
17. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
18. A pH-responsive mesoporous silica nanoparticle-based drug delivery system for targeted breast cancer therapy. Chang J; Mo L; Song J; Wang X; Liu H; Meng C; Wu Y J Mater Chem B; 2022 May; 10(17):3375-3385. PubMed ID: 35388835 [TBL] [Abstract][Full Text] [Related]
19. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release. Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741 [TBL] [Abstract][Full Text] [Related]
20. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source. Zhang K; Zhang Y; Li Y; Iqbal Z; Yu L; Liu J; Wang H; He P J Biomater Sci Polym Ed; 2021 Apr; 32(6):695-713. PubMed ID: 33297850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]